Potential benefit of involved-field radiotherapy for patients with relapsed-refractory Hodgkin's lymphoma with incomplete response prior to autologous stem cells transplantation

We investigated the role of radiotherapy in 73 patients receiving autologous stem cell transplant (ASCT) for relapsed/refractory Hodgkin lymphoma by comparing patients who received peri-transplant RT with patients who received chemotherapy alone.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 15, 2016 Category: Hematology Authors: Mario Levis, Cristina Piva, Andrea Riccardo Filippi, Barbara Botto, Paolo Gavarotti, Patrizia Pregno, Maura Nicolosi, Roberto Freilone, Guido Parvis, Daniela Gottardi, Umberto Vitolo, Umberto Ricardi Tags: Original Study Source Type: research